NLRP3 and age-related macular degeneration: In addition, a recent review of commercially available NLRP3 antibodies used in these studies has demonstrated the poor specificity and reliability of these products, finding that no studies showing evidence of NLRP3 involvement in AMD, or its presence in primary or established RPE cell lines, could be replicated30.